How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML).

Research output: Contribution to journalArticlepeer-review

Authors

Colleges, School and Institutes

Details

Original languageEnglish
JournalBritish Journal of Haematology
Publication statusE-pub ahead of print - Oct 2020